comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-06 03:38:53 - browse：8

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Let's speed up science by embracing open access publishing

WSS

HIV drugs protect against transmission, even in unprotected sex

Shifting the focus from loneliness to social health

Microsoft's Peter Lee: Generative AI could help doctors be more human

ASCO: Palliative care found as helpful given virtually as in person

The Pandemic Treaty must support building strong health systems

Medicare drug price negotiation continues, as pharma counteroffers

Wikipedia

comprehensive

Wikipedia

New air purifier tech could be key to improving indoor air quality

Cord blood banking comes at a high cost to babies

After affirmative action ruling, medical educators look to 'holistic review'

Ultragenyx gene therapy for rare liver ailment succeeds in late

Duchenne breakthrough therapy leaves behind pioneering families

ASCO: Palliative care found as helpful given virtually as in person

Activists slam private health insurers over coverage restrictions

A new approach to psychiatric drug development

ChatGPT in medicine: STAT answers readers' burning questions

The public health thinking behind the CDC’s new Covid guidance

focus

Why Talkspace is targeting Medicare, a tricky market

Change Healthcare: What is it, why does its cyberattack matter?

Intellia reports positive results for its CRISPR

Readout Newsletter: BridgeBio, Akero, and human embryo models

For AI in health care standards, federal regulators join with industry group

Intellia reports positive results for its CRISPR

Wikipedia

Wikipedia

focus

hotspot